1 April 2021

Kainos Group plc

("Kainos" or the "Company") 

Total Voting Rights

Pursuant to DTR 5.6.1 the Company announces that as at 1 April 2021, the total number of ordinary shares in issue now stands at 122,785,147 each with voting rights. There are no shares held in treasury.

The above figure (122,785,147) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the Company under the FCA's Disclosure and Transparency Rules.

Kainos Group plc Legal Entity Identifier: 213800H2PQMIF3OVZY47 

Classification: 2.5 - Total number of voting rights and capital

Ends

For further information, please contact:

Kainos                                                                                        via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

Investec Bank plc                                                                              +44 20 7597 5970

Patrick Robb / Ben Griffiths

Canaccord Genuity                                                                           +44 20 7523 4606

Simon Bridges/ Emma Gabriel

FTI Consulting LLP                                                                               +44 20 3727 1000

Matt Dixon / Dwight Burden / Kwaku Aning

About Kainos

Kainos Group plc is a UK-headquartered provider of Digital Services and Digital Platforms. 

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the leading European partner for Workday, Inc. ('Workday'), responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers. 

The Group's Digital Platforms comprise specialised digital platforms in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market-leading product for the digitisation of patient notes in the Acute sector of the NHS.

Kainos has over 1,700 people across 15 offices in Europe and North America.

Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit www.kainos.com.